Skip to content
Menu
Network
Sub-Menu
Browse by Subject
Browse by Publisher
Join the Network
Get Started
Subscribe
Support
Contact Us
Search
Close
Enter Search Terms
Search
John Greiss
ID:
1b83995e-2619-30fb-68c4
/
Claimed Record
/
Organization:
Norton Rose Fulbright
Published Works
23 articles
Certain COVID-19 medical devices no longer hold urgent public health need status under Interim Order No. 2
Pharma in Brief ·
July 22, 2021
cite
Food and Drug Regulations amended: COVID-19 drugs and vaccines transitioned out of interim order framework
Pharma in Brief ·
April 13, 2021
cite
Two new interim orders update previous orders on medical devices and foreign products during pandemic
Pharma in Brief ·
April 1, 2021
cite
Health Canada consults on proposed guidelines for the use of electronic media in prescription drug labelling
Pharma in Brief ·
March 18, 2021
cite
Health Canada consults on transition of interim order drugs, vaccines, and medical devices to permanent approval pathways
Pharma in Brief ·
December 3, 2020
cite
Previous
1
2
3
4
5
Next
Practice Areas
Health Care and Life Sciences
Jurisdictions
Canada
North America